
Merit Medical Systems, Inc.: updates and filings
Price
$84.41
November 19, 2026Market cap $5.0B
What Ploutos Investor adds for Merit Medical Systems
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 29, 2026next Jan 29, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
April 2026
February 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 29, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 20, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 30, 2026Results of operations, Regulation FD disclosureForm8-K
- Jun 29, 2026Shares registered for employeesFormS-8
- Jun 26, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 29, 2026Conflict minerals reportFormSD
- May 19, 2026Officer or director change, amended articles or bylaws, shareholder vote, Regulation FD disclosureForm8-K
- May 15, 2026Shares registered for employeesFormS-8
- Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 13, 2026Regulation FD disclosureForm8-K
- Apr 1, 2026Regulation FD disclosureForm8-K
- Mar 31, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 31, 2026Additional annual meeting materialFormDEFA14A
- Mar 31, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 24, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 24, 2026Results of operations, Regulation FD disclosureForm8-K
- Jan 8, 2026Results of operations, officer or director change, Regulation FD disclosureForm8-K
- Nov 13, 2025Regulation FD disclosureForm8-K
- Nov 3, 2025Regulation FD disclosureForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 29, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 20, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jul 30, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 30, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jun 29, 2026 | S-8 | Shares registered for employees | Document |
| Jun 26, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 29, 2026 | SD | Conflict minerals report | Document |
| May 19, 2026 | 8-K | Officer or director change, amended articles or bylaws, shareholder vote, Regulation FD disclosure | Document |
| May 15, 2026 | S-8 | Shares registered for employees | Document |
| Apr 30, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Apr 1, 2026 | 8-K | Regulation FD disclosure | Document |
| Mar 31, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 31, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 31, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 24, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 24, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jan 8, 2026 | 8-K | Results of operations, officer or director change, Regulation FD disclosure | Document |
| Nov 13, 2025 | 8-K | Regulation FD disclosure | Document |
| Nov 3, 2025 | 8-K | Regulation FD disclosure | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 14, 1996.
The full analysis
What do Merit Medical Systems's filings show?
The filings are where every one of Merit Medical Systems's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.